Stocks
3 ساعات، 12 دقيقة منذ
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?
For years, AstraZeneca has commanded one of the richest valuations among large European pharma companies on the assumption that it …
التأثير على AZN:
The trial flop may lead to a decline in AstraZeneca's stock price, …
AstraZeneca's trial flop raises concerns about its pipeline premium, potentially impacting its valuation and the …
الأعلى (80%)
عرض التحليل الكامل →